Like many employers, they wanted to know: What is the real impact of GLP-1s on diabetes? Specifically, they want to understand whether the investment in GLP-1s has been effective in a) helping their diabetic population of nearly 3,000 employees and members better manage their chronic disease and b) addressing the $40M+ in annual spend for this population
Bacteriostatic water is required for multi-dose vials
Concern was initially raised by the findings of the SUSTAIN-6 CVOT that suggested the risk of DR complications was elevated in patients using semaglutide compared with placebo (3.0% vs 1.8%, P = .02)
Learn more Our network handles intake, eligibility, and prescribing when appropriate so you don't need a medical license
You also learn how dosing works, how to administer the medication yourself, how to store the medication, and what to expect during the first few weeks
Participants receiving 1 mg per day of AOD 9604 lost approximately 2.6 kg compared to 0.8 kg in the placebo group